EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study

Jonathan Mandolo iD, Leah Mulira, Martha Moyo, Memory Mvula iD, Fatima Mtonga, Marc Y R Henrion iD, Willy Wotcheni, Nigel A Cunliffe, Kayla G Barnes iD, Kondwani C Jambo iD, Khuzwayo C Jere iD

PLOS Medicine · 2025

DOI: 10.1371/journal.pmed.1004734 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS Medicine, 2025. Verfasst von Jonathan Mandolo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Antibodies, Viral, Rotavirus Infections, Rotavirus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Gates Foundation, FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rotavirus vaccine protects against severe rotavirus-related gastroenteritis. Its effectiveness is substantially lower in low- and middle-income countries (LMICs) compared to high-income settings, partly due to interference from maternally derived rotavirus-specific immunoglobulin G (IgG) resulting from high rotavirus burden. These antibodies wane over time, reducing their capacity to inhibit vaccine-induced immune responses, including immunoglobulin A (IgA). We aimed to estimate the optimal window for administering an additional rotavirus vaccine dose, beyond the routine doses given at 6 and 10 weeks of age, to maximise immunogenicity in an LMIC, high-disease-burdened setting. Methods and Findings We collected longitudinal serum samples from 84 infants at five time points between January 2021 and October 2023, and cross-sectional serum samples from 798 healthy individuals aged 0–86 years between December 2022 and June 2024. For participants under 18 years of age, a written consent was obtained from parents or guardians, with assent from the child where appropriate, individuals aged 18 years and above provided written informed consent directly. Rotavirus-specific IgG and IgA concentrations were measured using a gold standard enzyme-linked immunosorbent assay (ELISA). Rotavirus gastroenteritis case data were extracted from ongoing surveillance during the same period. All participants were recruited from the Southern Region of Malawi, a rotavirus high-burden setting. We applied linear mixed-effects and generalised linear models with natural splines to assess age-dependent trends in antibody levels. Prior to scheduled Rotarix rotavirus vaccine dose 1, the median maternally derived rotavirus-specific IgG levels were significantly lower in infants who were seropositive following vaccination compared with those who remained seronegative (5,745.0 IU/ml versus 9,689.8 IU/ml; Wilcoxon-test, p = 0.015). Infants with the lowest maternal IgG levels were over five times more likely to seroconvert (odds ratio [OR] = 5.8, 95% confidence interval (CI): 1.6–24.2; Chi-square test, p = 0.012). An exponential decay model estimated that the median IgG concentration in non-seroconverters crossed the seroconversion-probability threshold at 6.2 months. Population-level analyses revealed IgG concentrations reached their nadir at 8.4 months, coinciding with a peak in severe rotavirus gastroenteritis cases at 9 months. Serum IgA levels peaked at 9 months and were associated with a decline in disease incidence between 9 and 17 months. Key limitations include the small number of non-seroconverting infants (n = 27) who were unexposed during follow-up and the observational study design. These factors may influence interpretation, but the findings nonetheless provide important insights into rotavirus antibody dynamics.

Conclusions

These findings suggest that administering a booster dose between 6 and 8 months of age, when maternal antibody titer is low and severe rotavirus gastroenteritis risk is high, may enhance the immunogenicity and effectiveness of the rotavirus vaccine in LMICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesAntibodies, ViralRotavirus InfectionsRotavirusImmunization, SecondaryImmunity, Maternally-AcquiredHumansInfantMalawiFemaleMaleAdultImmunoglobulin GYoung AdultCross-Sectional StudiesChild, PreschoolImmunoglobulin AAdolescentInfant, NewbornGastroenteritisMiddle AgedChildAgedTime Factors

Substanzen

Rotavirus VaccinesAntibodies, ViralImmunoglobulin GImmunoglobulin A

Autor:innen und Institutionen

  • Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi.
  • Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, United States of America.
  • Kamuzu University of Health Sciences, Blantyre, Malawi.

ORCID-Profile: Jonathan Mandolo, Memory Mvula, Marc Y R Henrion, Kayla G Barnes, Kondwani C Jambo, Khuzwayo C Jere

Förderung

  • Wellcome Trust
  • Gates Foundation
  • FIC NIH HHS
  • Foundation for the National Institutes of Health
  • Research England

Zitieren

APA

Mandolo, J., Mulira, L., Moyo, M., Mvula, M., Mtonga, F., Henrion, M. Y. R., Wotcheni, W., Cunliffe, N. A., Barnes, K. G., Jambo, K. C., & Jere, K. C. (2025). Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004734

Vancouver

Mandolo J, Mulira L, Moyo M, Mvula M, Mtonga F, Henrion MYR, et al. Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study. PLOS Medicine. 2025. doi:10.1371/journal.pmed.1004734

BibTeX
@article{Mandolo2025,
  author = {Mandolo, Jonathan and Mulira, Leah and Moyo, Martha and Mvula, Memory and Mtonga, Fatima and Henrion, Marc Y R and Wotcheni, Willy and Cunliffe, Nigel A and Barnes, Kayla G and Jambo, Kondwani C and Jere, Khuzwayo C},
  title = {Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study},
  journal = {PLOS Medicine},
  year = {2025},
  doi = {10.1371/journal.pmed.1004734}
}
Kostenlos starten →